Learn more
Selvita
About us
Drug Discovery
Discovery Areas
Integrated Drug Discovery
AI-driven Drug Discovery
Structural Biology
Crystallography
Fast-track crystallization
Crystallization screening service
Recombinant protein production
Membrane protein production
QC studies of recombinant proteins
Assay Development & Screening
HTS
HCS
Biophysical Platform
Fragment-Based Drug Discovery
Libraries
ADME/DMPK
HIDDEN
Chemistry
CADD
Medicinal & Synthetic Chemistry
Scale-up
Analytical Chemistry
Solid State Chemistry
Selvita’s experience with different chemotypes
In vitro Pharmacology
In vivo Pharmacology
Toxicology
Translational Research
Therapeutic areas
Oncology
Infectious diseases
Inflammation
Fibrosis
Neurosciences
Respiratory
Drug Development
Small Molecules
Method development, validation, and transfer
Raw materials and APIs quality control
cGMP Batch release testing
ICH Stability Testing and Storage
Elemental impurities determination according to ICH Q3D
Pharmaceutical impurities identification, determination and testing
Nitrosamines determination and testing
Pyrrolizidine alkaloids (PAs) determination and testing
Cleaning validation
Bioequivalence studies
Equipment
Biologics
Method development, validation and transfer
Quality control of drug substances, excipients, and drug products
cGMP Batch release testing
Analytical support in Formulation Development
Analytical support for the biosimilars registration process
ICH Q6B Testing
Physicochemical properties determination
Binding properties and potency assays
Process- and product-related impurities determination
Selvita’s experience in working with growth factors, hormones, and mAbs
Equipment
R&D
Agrochemistry analytical support
Flavours and Fragrances
Selvita’s experience with different chemotypes
Sample submission requirements
Our science
Blog
Scientific resources
Webinars & videos
Investors & Media
News
Reports
Financial Results
Shareholder Structure
Corporate information
Careers
Contact
PL
Investors & Media
General meetings
Home
Investors & Media
General meetings
Reports
2023
Periodic
Current
Show
31 May 2023
Announcement on the Ordinary General Shareholders Meeting convened for June 27th, 2023
More
Empty list
Subscribe to receive news updates
from Selvita
I agree with Selvita
privacy policy
Subscribe
Contacts
Media Relations
[email protected]
Investor Relations
[email protected]
Download media package
Ready to partner with us?
Get started
